- $1.95bn
- $4.55bn
- $4.19bn
- 52
- 77
- 87
- 83
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 2,991 | 3,549 | 4,131 | 4,191 |
Cost of Revenue | ||||
Gross Profit | 670 | 892 | 919 | 933 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 2,775 | 3,301 | 3,862 | 3,920 |
Operating Profit | 216 | 248 | 269 | 271 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 240 | 251 | 157 | 107 |
Provision for Income Taxes | ||||
Net Income After Taxes | 192 | 187 | 107 | -132 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | 191 | 186 | 108 | -134 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 191 | 186 | 108 | -134 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 3.69 | 3.91 | 2.22 | -0.075 |
Dividends per Share |